Alejandro Molina-Leyva Selected Research

Hidradenitis Suppurativa

2/2022	Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa.
1/2022	Potential Benefits of the Mediterranean Diet and Physical Activity in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study in a Spanish Population.
11/2021	Cumulative Inflammation and HbA1c Levels Correlate with Increased Intima-Media Thickness in Patients with Severe Hidradenitis Suppurativa.
7/2021	The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study.
1/2021	The role of biologic treatment in special scenarios in hidradenitis suppurativa: Facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema.
1/2021	The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
11/2020	Clinical selection criteria in new clinical trials of hidradenitis suppurativa: External validity and implications on the daily clinical practice.
10/2020	Publisher Correction: Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa.
9/2020	Neoadjuvant Biologic Therapy in the Surgical Management of Patients with Hidradenitis Suppurativa: A Cohort Study.
1/2020	The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alejandro Molina-Leyva Research Topics

Disease

17	Hidradenitis Suppurativa 02/2022 - 10/2018
8	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2021 - 11/2013
3	Alopecia Areata 03/2022 - 11/2020
3	Alopecia (Baldness) 09/2021 - 04/2016
3	Erythema 08/2021 - 04/2021
2	Fistula 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 11/2021 - 09/2021
2	Abscess 01/2021 - 01/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 05/2020 - 12/2017
1	Actinic Keratosis 07/2022
1	Atopic Dermatitis (Atopic Eczema) 06/2022
1	COVID-19 04/2022
1	Hypothyroidism 03/2022
1	Inflammation (Inflammations) 11/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Familial Perifolliculitis Capitis Abscedens Et Suffodiens 01/2021
1	Lymphedema (Milroy Disease) 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Cicatrix (Scar) 11/2020
1	Weight Loss (Weight Reduction) 05/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Porokeratosis (Palmoplantar Porokeratosis) 01/2020
1	Pruritus (Itching) 01/2020
1	Folliculitis (Sycosis) 07/2013

Drug/Important Bio-Agent (IBA)

5	Adalimumab (Humira)FDA Link 02/2022 - 01/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 01/2020
4	Biological ProductsIBA 02/2022 - 01/2019
3	Clindamycin (Cleocin)FDA LinkGeneric 01/2021 - 03/2019
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 03/2019
3	Ustekinumab (CNTO 1275)FDA Link 01/2020 - 11/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 09/2021 - 11/2013
2	Melanins (Melanin)IBA 07/2021 - 04/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 08/2014
1	AcidsIBA 07/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2022
1	dupilumabIBA 06/2022
1	Biosimilar PharmaceuticalsIBA 02/2022
1	tofacitinibIBA 01/2022
1	Insulin (Novolin)FDA Link 11/2021
1	Vitamin D FDA LinkGeneric 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	LipidsIBA 11/2021
1	Minoxidil (Rogaine)FDA LinkGeneric 09/2021
1	AntioxidantsIBA 08/2021
1	Oral ContraceptivesIBA 07/2021
1	Androgen Antagonists (Antiandrogens)IBA 07/2021
1	AntibodiesIBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2021
1	TetracyclinesIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Olive OilIBA 05/2020
1	guselkumabIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	E-SelectinIBA 01/2018
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 12/2017
1	Finasteride (Propecia)FDA LinkGeneric 04/2016
1	Complement System Proteins (Complement)IBA 01/2014

Therapy/Procedure

9	Therapeutics 07/2022 - 03/2019
4	Biological Therapy 12/2021 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 07/2022 - 01/2020
2	Mediterranean Diet 01/2022 - 05/2020
2	Phototherapy (Light Therapy) 08/2021 - 07/2021
1	Hand Hygiene 04/2022
1	Injections 01/2022
1	Intravenous Infusions 01/2020
1	Baths 07/2013